[1]
Bokemeyer C, Nichols CR, Droz JP, Schmoll HJ, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Hartmann JT. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Apr 1:20(7):1864-73
[PubMed PMID: 11919246]
[2]
Dieckmann KP, Richter-Simonsen H, Kulejewski M, Ikogho R, Zecha H, Anheuser P, Pichlmeier U, Isbarn H. Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation. Urologia internationalis. 2018:100(4):409-419. doi: 10.1159/000488284. Epub 2018 Apr 12
[PubMed PMID: 29649815]
[3]
Chung P, Warde P. Testicular cancer: seminoma. BMJ clinical evidence. 2011 Jan 25:2011():. pii: 1807. Epub 2011 Jan 25
[PubMed PMID: 21477387]
[4]
Fung C, Dinh PC, Fossa SD, Travis LB. Testicular Cancer Survivorship. Journal of the National Comprehensive Cancer Network : JNCCN. 2019 Dec:17(12):1557-1568. doi: 10.6004/jnccn.2019.7369. Epub
[PubMed PMID: 31805527]
[5]
Batool A, Karimi N, Wu XN, Chen SR, Liu YX. Testicular germ cell tumor: a comprehensive review. Cellular and molecular life sciences : CMLS. 2019 May:76(9):1713-1727. doi: 10.1007/s00018-019-03022-7. Epub 2019 Jan 22
[PubMed PMID: 30671589]
[6]
Barchi M, Innocenzi E, Giannattasio T, Dolci S, Rossi P, Grimaldi P. Cannabinoid Receptors Signaling in the Development, Epigenetics, and Tumours of Male Germ Cells. International journal of molecular sciences. 2019 Dec 18:21(1):. doi: 10.3390/ijms21010025. Epub 2019 Dec 18
[PubMed PMID: 31861494]
[7]
Gurney J, Shaw C, Stanley J, Signal V, Sarfati D. Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC cancer. 2015 Nov 11:15():897. doi: 10.1186/s12885-015-1905-6. Epub 2015 Nov 11
[PubMed PMID: 26560314]
Level 1 (high-level) evidence
[8]
Garolla A, Vitagliano A, Muscianisi F, Valente U, Ghezzi M, Andrisani A, Ambrosini G, Foresta C. Role of Viral Infections in Testicular Cancer Etiology: Evidence From a Systematic Review and Meta-Analysis. Frontiers in endocrinology. 2019:10():355. doi: 10.3389/fendo.2019.00355. Epub 2019 Jun 12
[PubMed PMID: 31263452]
Level 1 (high-level) evidence
[9]
Fukawa T, Kanayama HO. Current knowledge of risk factors for testicular germ cell tumors. International journal of urology : official journal of the Japanese Urological Association. 2018 Apr:25(4):337-344. doi: 10.1111/iju.13519. Epub 2018 Jan 17
[PubMed PMID: 29345008]
[10]
Coffey J, Linger R, Pugh J, Dudakia D, Sokal M, Easton DF, Timothy Bishop D, Stratton M, Huddart R, Rapley EA. Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literature. Genes, chromosomes & cancer. 2008 Jan:47(1):34-42
[PubMed PMID: 17943970]
[11]
Ghazarian AA, Trabert B, Devesa SS, McGlynn KA. Recent trends in the incidence of testicular germ cell tumors in the United States. Andrology. 2015 Jan:3(1):13-8. doi: 10.1111/andr.288. Epub 2014 Oct 20
[PubMed PMID: 25331158]
[12]
Nigam M, Aschebrook-Kilfoy B, Shikanov S, Eggener S. Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World journal of urology. 2015 May:33(5):623-31. doi: 10.1007/s00345-014-1361-y. Epub 2014 Jul 17
[PubMed PMID: 25030752]
[13]
Sheikine Y, Genega E, Melamed J, Lee P, Reuter VE, Ye H. Molecular genetics of testicular germ cell tumors. American journal of cancer research. 2012:2(2):153-67
[PubMed PMID: 22432056]
[14]
Tourne M, Radulescu C, Allory Y. [Testicular germ cell tumors: Histopathological and molecular features]. Bulletin du cancer. 2019 Apr:106(4):328-341. doi: 10.1016/j.bulcan.2019.02.004. Epub 2019 Mar 21
[PubMed PMID: 30905378]
[15]
Zores T, Mouracade P, Duclos B, Saussine C, Lang H, Jacqmin D. [Surveillance of stage I testicular seminoma: 20 years oncological results]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2015 Apr:25(5):282-7. doi: 10.1016/j.purol.2015.01.009. Epub 2015 Feb 25
[PubMed PMID: 25724863]
[16]
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Feb
[PubMed PMID: 9053482]
Level 3 (low-level) evidence
[17]
Stokes W, Amini A, Maroni PD, Kessler ER, Stokes C, Cost CR, Greffe BS, Garrington TP, Liu AK, Cost NG. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis. Journal of pediatric urology. 2017 Aug:13(4):386.e1-386.e7. doi: 10.1016/j.jpurol.2016.12.009. Epub 2017 Jan 17
[PubMed PMID: 28153774]
[18]
Chovanec M, Hanna N, Cary KC, Einhorn L, Albany C. Management of stage I testicular germ cell tumours. Nature reviews. Urology. 2016 Nov:13(11):663-673. doi: 10.1038/nrurol.2016.164. Epub 2016 Sep 13
[PubMed PMID: 27618772]
[19]
Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Shuch B, Sircar K, Somer B, Wilder RB, Dwyer M, Kumar R. Testicular Cancer, Version 2.2015. Journal of the National Comprehensive Cancer Network : JNCCN. 2015 Jun:13(6):772-99
[PubMed PMID: 26085393]
[20]
Faouzi S, Ouguellit S, Loriot Y. [Stage 1 germ-cell tumour]. Bulletin du cancer. 2019 Oct:106(10):887-895. doi: 10.1016/j.bulcan.2019.03.010. Epub 2019 May 12
[PubMed PMID: 31088678]
[21]
Stephenson A, Eggener SE, Bass EB, Chelnick DM, Daneshmand S, Feldman D, Gilligan T, Karam JA, Leibovich B, Liauw SL, Masterson TA, Meeks JJ, Pierorazio PM, Sharma R, Sheinfeld J. Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. The Journal of urology. 2019 Aug:202(2):272-281. doi: 10.1097/JU.0000000000000318. Epub 2019 Jul 8
[PubMed PMID: 31059667]
[22]
Alsdorf W,Seidel C,Bokemeyer C,Oing C, Current pharmacotherapy for testicular germ cell cancer. Expert opinion on pharmacotherapy. 2019 May;
[PubMed PMID: 30849243]
Level 3 (low-level) evidence
[23]
Fizazi K, Delva R, Caty A, Chevreau C, Kerbrat P, Rolland F, Priou F, Geoffrois L, Rixe O, Beuzeboc P, Malhaire JP, Culine S, Aubelle MS, Laplanche A. A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study. European urology. 2014 Feb:65(2):381-6. doi: 10.1016/j.eururo.2013.09.004. Epub 2013 Sep 13
[PubMed PMID: 24094847]
[24]
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA: a cancer journal for clinicians. 2017 Mar:67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17
[PubMed PMID: 28094848]
[25]
Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, Dearnaley DP. Cardiovascular disease as a long-term complication of treatment for testicular cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Apr 15:21(8):1513-23
[PubMed PMID: 12697875]